THC and Anandamide Produced Similar Movement Effects but Different Forebrain c-Fos Patterns in Rats

THC and anandamide produced similar reductions in movement and temperature in rats while differing in regional c-fos expression. Similar outward effects therefore did not establish identical forebrain responses.

The study compared acute injected compounds

Rats received THC or anandamide before behavioral and gene-expression assessment. The abstract noted a shorter apparent duration for anandamide. The administered doses were not equivalent measures of receptor exposure, and an injected endogenous ligand should not be equated with normal physiological release.

Some regions responded similarly

Both compounds produced high c-fos expression in the hypothalamic paraventricular nucleus and lateral septum. Both increased expression in the central amygdala, although THC's effect was greater. Only THC produced significant increases in the nucleus accumbens and caudate-putamen in the reported comparisons.

c-Fos does not identify a complete behavioral mechanism

The authors proposed differences in receptor activation or downstream efficacy as possible explanations. Those possibilities were not established as a single causal account by the regional pattern alone. c-fos is an activity-related gene measure, not direct proof of euphoria, addiction, injury or functional impairment.

The findings support qualitative differences between two cannabinoid agonists despite overlapping behavioral effects. Their strongest use is to caution against treating one visible response as a complete description of a drug's actions. They do not establish that anandamide and THC are interchangeable or predict an individual's response to cannabis.

Related: interpreting cannabis tolerance claims.

Research cited

McGregor IS; Arnold JC; Weber MF; Topple AN; Hunt GE. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. Brain research (1998). doi:10.1016/s0006-8993(98)00549-6. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us